small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 81 results

Industry

Development & Protection of AI Technologies

Our Intellectual Property (IP) and Privacy teams work closely together to counsel clients in building, protecting, and commercializing proprietary AI technologies and data; the use of third party or open source AI technologies and data; and the implications that these activities may have under privacy laws....Read more

Practice Area

REITs

Our REIT attorneys are experienced in the planning and implementation of a variety of organizational and real estate ownership structures used for REIT formations and transactions. We understand the complex requirements of asset ownership and character of income that must be met to qualify for pass-through tax treatment under the Internal Revenue Code. Our team has extensive experience with IPOs, private placement of debt, securitization of debt, public/private preferred and common equity offerings, PIPE transactions, recapitalizations, trust preferred securities, asset purchase and dispositions, §1031 exchanges, and mergers and acquisitions. Our experience in capital raising (via public and private securities offerings), securitization, and structured finance transactions is just as deep....Read more

Practice Area

Labor & Employment

Our Labor & Employment Practice is one of the largest and most experienced practices among the country’s multi-disciplined law firms. Our attorneys represent global employers of all types and sizes—ranging from the Fortune 100 to privately held startups—often serving as national, regional, or preferred counsel to many of these major employers....Read more

Experience 170 results

Experience

|

September 23, 2025

Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals

Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).  ...Read more

Experience

|

September 9, 2025

Greenland Exploration Limited enters business combination with Pelican Acquisition Corporation and March GL Company

Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms....Read more

Experience

|

July 17, 2025

D. Boral Capital Closes US$15M Robot Consulting IPO

Winston & Strawn LLP represented D. Boral Capital LLC and Craft Capital Management LLC in connection with the US$15M initial public offering of American Depositary Shares (ADSs) of Robot Consulting Co., Ltd. The offering consisted of 3,750,000 ADSs priced at $4.00 per ADS, and the company’s ADSs began trading on the Nasdaq Capital Market under the ticker symbol “LAWR” on July 17, 2025....Read more
View All Experience

Insights & News 4,122 results

False Claims Act Playbook

|

October 30, 2025

|

5 Min Read

Private Equity Firm Avoids Potential False Claims Act Liability in Dismissal from Whistleblower Suit Brought by Healthcare Portfolio Company Executive

On October 15, 2025, the United States District Court for the District of Nebraska (the Court) dismissed Pharos Capital Group and its related investment funds (Pharos Capital) from a qui tam or whistleblower suit brought under the antiretaliation provision of the False Claims Act (31 U.S.C. § 3730(h)) (the FCA), against Pharos Capital and Charter Health Care Group (Charter), a portfolio company of Pharos Capital.

Winston’s Environmental Law Update

|

October 30, 2025

|

5 Min Read

E15 Gasoline: Legal Landscape and Recent Legislative Updates

The EPA establishes a national standard for gasoline volatility (Reid vapor pressure, or RVP) via section 211(h) of the Clean Air Act to reduce emissions of volatile organic compounds.

Winston’s AI Top 10

|

October 2025

|

5 Min Read

Winston’s AI Monthly Recap - October 2025

Winston’s AI Top 10 summarizes the latest AI developments in the legal industry.

View All Insights & News

Other Results 74 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

In Memoriam:
David A. Coulson

Law Glossary

What Is the Purple Book?

Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising